Overview: Trials stopping early in head and neck cancer Head and neck cancer trials are frequently derailed before they can provide clear answers. A recent analysis highlights that the leading reasons are sponsor decisions tied to safety or effectiveness and difficulties enrolling suitable patients. These disruptions can delay potentially beneficial treatments for years and complicate…